Dr Lawrence King is a Partner and UK Chartered and European Patent Attorney in the Chemistry, Biotechnology and Pharmaceuticals patent department. Lawrence has specialist expertise in chemistry, chemical engineering and pharmaceuticals.
The Legal 500 2019 edition has now been published and we are delighted that the firm has once again been ranked as a leading firm for both patents and trade marks, and that our level of service was recognised, once again, as “outstanding”: “The ‘excellent’ A.A. Thornton & Co. ‘goes the extra mile to provide outstanding customer service’ and has… Read more »
The Legal 500 2017 edition has now been published and we are delighted that the firm has once again been ranked as a leading firm for both patents and trade marks, and that our level of service was recognised as “outstanding”. The editorial sections for each of our entries in the directory are reproduced below: “A.A. Thornton & Co.’s level… Read more »
On 15 October 2014, partners of the firm Craig Turner, Adrian Bennett, Mike Jennings and Lawrence King took part in the Halliburton Charity Golf Tournament.
Speaking at the in-cosmetics Korea exhibition, Seoul We are excited to announce that Consulting Patent Attorney and Cosmetics & Personal Care industry team member Julie Barrett-Major will be speaking at the in-cosmetics Korea exhibition on 13 June 2018. Julie’s long career history in this field lends itself to her topic of choice: “Patents – an excellent way of finding out… Read more »
The UK Court of Appeal has recently handed down a judgment concerning the validity of patents relating to enantiomers of biologically active compounds.
On 11 December 2012, the European Parliament voted in favour of implementing the EU Regulation that gives effect to the European patent with unitary effect (“unitary patent”).
This article summarises the current system for obtaining and enforcing patents in Europe and the key features of the proposed unitary European patent and Unified Patent Court.